USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS (Q4244517): Difference between revisions
From MaRDI portal
Set profile property. |
Created claim: Wikidata QID (P12): Q52220712, #quickstatements; #temporary_batch_1712261475387 |
||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q52220712 / rank | |||
Normal rank | |||
Revision as of 22:28, 4 April 2024
scientific article; zbMATH DE number 1292936
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS |
scientific article; zbMATH DE number 1292936 |
Statements
USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS (English)
0 references
5 September 1999
0 references
interim analyses
0 references
therapeutic equivalence
0 references
beta-binomial distribution
0 references
